Issue 8/2019
Content (21 Articles)
Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials
A. Mott, T. Bradley, K. Wright, E. S. Cockayne, M. J. Shearer, J. Adamson, S. A. Lanham-New, D. J. Torgerson
Vertebral bone attenuation in Hounsfield Units and prevalent vertebral fractures are associated with the short-term risk of vertebral fractures in current and ex-smokers with and without COPD: a 3-year chest CT follow-up study
M.J. van Dort, J.H.M. Driessen, P. Geusens, E.A.P.M. Romme, F.W.J.M. Smeenk, E.F.M. Wouters, J.P.W. van den Bergh
A case-control pilot study of stress fracture in adolescent girls: the discriminative ability of two imaging technologies to classify at-risk athletes
R. L. Duckham, S. R. Bialo, J. Machan, P. Kriz, C. M. Gordon
Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis
W. Zhou, Y. Liu, X. Guo, H. Yang, Y. Xu, D. Geng
Correlation between hip osteoarthritis and proximal femoral fracture site: could it be protective for intracapsular neck fractures? A retrospective study on 320 cases
Tommaso Maluta, Giovanna Toso, Stefano Negri, Elena Manuela Samaila, Bruno Magnan
Challenges and opportunities to improve fracture liaison service attendance: fracture registration and patient characteristics and motivations
P. van den Berg, P.M.M. van Haard, P.P. Geusens, J.P. van den Bergh, D.H. Schweitzer
Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
H. Chandler, D.J. Brooks, G. Hattersley, M.L. Bouxsein, B. Lanske
Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan
W.-J. Hong, W. Chen, K.-J. Yeo, P.-H. Huang, D.-Y. Chen, J.-L. Lan
Patients’ reasons for adhering to long-term alendronate therapy
J. Pepe, C. Cipriani, V. Cecchetti, C. Ferrara, G. Della Grotta, V. Danese, L. Colangelo, S. Minisola
Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study
W.M. Hopman, C. Berger, L. Joseph, S.N. Morin, T. Towheed, T. Anastassiades, J.D. Adachi, D.A. Hanley, J.C. Prior, D. Goltzman
Dietary inflammatory index® and cortical bone outcomes in healthy adolescent children
L. M. Coheley, N. Shivappa, J. R. Hebert, R. D. Lewis
High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis
T. Rupp, S. Butscheidt, E. Vettorazzi, R. Oheim, F. Barvencik, M. Amling, T. Rolvien
Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures
M. H. Jensen, P. Vestergaard
Five-year refracture rates of a province-wide fracture liaison service
R. Sujic, D.E. Beaton, M. Mamdani, S.M. Cadarette, J. Luo, S. Jaglal, J.E.M. Sale, R. Jain, E. Bogoch
Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis
M. M. Sampaio-Barros, J. C. Alvarenga, L. Takayama, A. P. L. Assad, P. D. Sampaio-Barros, R. M. R. Pereira
Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study
M.W. Aref, E.A. Swallow, C.E. Metzger, N. Chen, S.M. Moe, M.R. Allen
Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1
K. G. Zarnecki, J. Kristianto, J. Charlson, B. Wilson, R. D. Blank, J. L. Shaker
Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis
S. Noe, H. Jaeger, E. Wolf
Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf
E. Biver, A. Calmy, C. Meier
Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge
K. Hygum, T. Harsløf, B. Langdahl, J. Starup-Linde